publication venue for
- Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity? 2022
- Protecting the Medically Vulnerable Amid COVID-19: Insights from the Dually Eligible Population in the United States. 2021
- Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. 2019